微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[26] 发布: 2013/05/15 17:33:08
NASDAQ Salix expects top-line phase III data from two studies on budesonide foam by the end of this month. The company is looking to seek FDA approval for budesonide foam for the treatment of moderate ulcerative proctitis or proctosigmoiditis by late Sep 2013. and more »
已读[22] 发布: 2013/05/14 17:23:03
Genetic Engineering News Assets include manufacturing equipment, formulation know-how, and the regulatory dossiers for European approved products delivered in Clickhaler...
已读[24] 发布: 2013/05/14 17:23:00
MarketWatch (press release) A doctor may recommend controlling asthma symptoms with SYMBICORT� ( budesonide /formoterol fumarate dihydrate) inhalation aerosol, a combination of inhaled corticosteroid (ICS) and long-acting beta2-adrenergic agonist (LABA). SYMBICORT is a ...
已读[23] 发布: 2013/05/14 17:22:59
The Times Group (blog) Some of the surveyed drugs include beclometasone which was available in some instances alongside salbutamol in private and public hospitals alongside procurement centre however; budesonide was not available in all the three. And Ministry of Health ...
已读[24] 发布: 2013/05/14 17:22:57
Zacks.com Salix expects top-line phase III data from two studies on budesonide foam by the end of this month. The company is looking to seek FDA approval for budesonide foam for the treatment of moderate ulcerative proctitis or proctosigmoiditis by late Sep 2013. and more »
已读[23] 发布: 2013/05/13 17:18:57
The Pharma Letter The assets include manufacturing equipment, formulation know-how and the regulatory dossiers for European approved products including salbutamol and b...
已读[23] 发布: 2013/05/13 17:18:55
PharmaTimes ... $30 milestone payment to GSK. Breo Ellipta is the follow-up to GSK's own twice-daily Advair (salmeterol/fluticasone), which is approved for asthma as w...
已读[26] 发布: 2013/05/11 17:15:31
华邦颖泰 “右布地奈德鼻喷雾剂”、“右布地奈德”新药目前处于“在审评”阶段,“R-布地奈德”、“R-布地奈德鼻喷雾剂”为“批准临床”;天药股份“布地...
已读[43] 发布: 2013/05/11 17:15:20
MarketWatch UCERIS(TM)( budesonide ) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID(R) (omeprazole/sodium bicarbonate) for the treatment of certain upper gastrointestinal disorders are ... and more »
已读[26] 发布: 2013/05/11 17:15:09
MedPage Today The FDA has approved two other inhaled corticosteroid/LABA combination products for COPD: fluticasone propionate/salmeterol (Advair Diskus) and budesonide...
« 上一页  |   查看结果111-120共137   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘